The history of the erectile dysfunction drug presents a intricate picture for investors. While the initial introduction generated substantial profits, the expiration of its patent opened the floodgates to off-brand https://wildbookmarks.com/story21837719/the-copyright-and-pharma-a-risky-opportunity